These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 25117299)

  • 1. Cumulative effects of genetic markers and the detection of advanced colorectal neoplasias by population screening.
    Kurlapska A; Serrano-Fernández P; Baszuk P; Gupta S; Starzyńska T; Małecka-Panas E; Dabrowski A; Dębniak T; Kurzawski G; Suchy J; Rogoza-Mateja W; Scott RJ; Lubiński J
    Clin Genet; 2015 Sep; 88(3):234-40. PubMed ID: 25117299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility genetic variants associated with early-onset colorectal cancer.
    Giráldez MD; López-Dóriga A; Bujanda L; Abulí A; Bessa X; Fernández-Rozadilla C; Muñoz J; Cuatrecasas M; Jover R; Xicola RM; Llor X; Piqué JM; Carracedo A; Ruiz-Ponte C; Cosme A; Enríquez-Navascués JM; Moreno V; Andreu M; Castells A; Balaguer F; Castellví-Bel S;
    Carcinogenesis; 2012 Mar; 33(3):613-9. PubMed ID: 22235025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of common genetic variants with colorectal cancer risk in a Romanian sample.
    Mateş IN; Csiki I; Mateş D; Constantinescu V; Badea P; Dinu D; Constantin A; Constantinoiu S
    Chirurgia (Bucur); 2010; 105(6):749-57. PubMed ID: 21351697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of genome-wide association study-identified genetic variants for colorectal cancer in a Chinese population.
    Xiong F; Wu C; Bi X; Yu D; Huang L; Xu J; Zhang T; Zhai K; Chang J; Tan W; Cai J; Lin D
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1855-61. PubMed ID: 20530476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a risk stratification-based screening model for predicting colorectal advanced neoplasia in Korea.
    Kim DH; Cha JM; Shin HP; Joo KR; Lee JI; Park DI
    J Clin Gastroenterol; 2015 Jan; 49(1):41-9. PubMed ID: 24583751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.
    Auge JM; Pellise M; Escudero JM; Hernandez C; Andreu M; Grau J; Buron A; López-Cerón M; Bessa X; Serradesanferm A; Piracés M; Macià F; Guayta R; Filella X; Molina R; Jimenez W; Castells A;
    Gastroenterology; 2014 Sep; 147(3):628-636.e1. PubMed ID: 24937264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah.
    Samadder NJ; Curtin K; Tuohy TM; Rowe KG; Mineau GP; Smith KR; Pimentel R; Wong J; Boucher K; Burt RW
    Gastroenterology; 2014 Oct; 147(4):814-821.e5; quiz e15-6. PubMed ID: 25042087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype.
    Abulí A; Bessa X; González JR; Ruiz-Ponte C; Cáceres A; Muñoz J; Gonzalo V; Balaguer F; Fernández-Rozadilla C; González D; de Castro L; Clofent J; Bujanda L; Cubiella J; Reñé JM; Morillas JD; Lanas A; Rigau J; García AM; Latorre M; Saló J; Fernández Bañares F; Argüello L; Peña E; Vilella A; Riestra S; Carreño R; Paya A; Alenda C; Xicola RM; Doyle BJ; Jover R; Llor X; Carracedo A; Castells A; Castellví-Bel S; Andreu M;
    Gastroenterology; 2010 Sep; 139(3):788-96, 796.e1-6. PubMed ID: 20638935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Death receptor 4 variants and colorectal cancer risk.
    Frank B; Shanmugam KS; Beckmann L; Hemminki K; Brenner H; Hoffmeister M; Chang-Claude J; Burwinkel B
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):2002-5. PubMed ID: 17035413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single nucleotide polymorphisms in colorectal cancer: associations with tumor site and TNM stage.
    Mates IN; Jinga V; Csiki IE; Mates D; Dinu D; Constantin A; Jinga M
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):45-52. PubMed ID: 22457859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer.
    Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam ME; Dekker E; van Ballegooijen M; Kuipers EJ; Fockens P; Kraaijenhagen RA; Bossuyt PM
    Cancer Epidemiol; 2013 Jun; 37(3):278-83. PubMed ID: 23491770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors.
    Cottet V; Pariente A; Nalet B; Lafon J; Milan C; Olschwang S; Bonaiti-Pellié C; Faivre J; Bonithon-Kopp C;
    Gastroenterology; 2007 Oct; 133(4):1086-92. PubMed ID: 17919484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of colorectal cancer and adenomas in the families of patients with adenomas: a population-based study in Utah.
    Tuohy TM; Rowe KG; Mineau GP; Pimentel R; Burt RW; Samadder NJ
    Cancer; 2014 Jan; 120(1):35-42. PubMed ID: 24150925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation-related gene polymorphisms and colorectal adenoma.
    Gunter MJ; Canzian F; Landi S; Chanock SJ; Sinha R; Rothman N
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1126-31. PubMed ID: 16775170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy.
    Brenner H; Chang-Claude J; Jansen L; Knebel P; Stock C; Hoffmeister M
    Gastroenterology; 2014 Mar; 146(3):709-17. PubMed ID: 24012982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of CTLA-4 A49G polymorphism with colorectal cancer risk in a Chinese Han population.
    Wang Y; Wang X; Zhao R
    Int J Immunogenet; 2015 Apr; 42(2):93-9. PubMed ID: 25689638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy.
    Brenner H; Haug U; Arndt V; Stegmaier C; Altenhofen L; Hoffmeister M
    Gastroenterology; 2010 Mar; 138(3):870-6. PubMed ID: 19909750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.
    Samadder NJ; Curtin K; Tuohy TM; Pappas L; Boucher K; Provenzale D; Rowe KG; Mineau GP; Smith K; Pimentel R; Kirchhoff AC; Burt RW
    Gastroenterology; 2014 Apr; 146(4):950-60. PubMed ID: 24417818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma.
    Berndt SI; Huang WY; Chatterjee N; Yeager M; Welch R; Chanock SJ; Weissfeld JL; Schoen RE; Hayes RB
    Carcinogenesis; 2007 Sep; 28(9):1965-70. PubMed ID: 17615257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.